In the plasma of SCLC patients, the level of PON1 was significantly reduced, while the fucosylation level of PON1 was significantly increased, suggesting that PON1 and its fucosylation level can be used as a diagnostic marker of SCLC (43). Here, PON1 is linked to small cell lung carcinoma.